ACB:CA:TSX-Aurora Cannabis Inc (CAD)

COMMON STOCK | Drug Manufacturers—Specialty & Generic | TSX

Last Closing Price

CAD 13.74

Change

0.00 (0.00)%

Market Cap

CAD 2.52B

Volume

0.02B

Average Target Price

CAD 12.29 (-10.54%)
Average Analyst Rating

Verdict

Fundamental Analysis

Verdict

About

Aurora Cannabis Inc. produces and distributes medical cannabis products worldwide. It is vertically integrated and horizontally diversified across various segments of the cannabis value chain, including facility engineering and design, cannabis breeding, genetics research, production, derivatives, high value-add product development, home cultivation, wholesale, and retail distribution. The company produces various strains of dried cannabis, cannabis oil and capsules, and topical kits for medical patients. It also sells vaporizers; consumable vaporizer accessories, including valves, screens, etc.; and herb mills for using CanniMed herbal cannabis products, as well as grinders and vaporizer lockable containers. In addition, the company engages in the development of medical cannabis products at various stages of development, including oral, topical, edible, and inhalable products; and operation of CanvasRX, a network of cannabis counseling and outreach centers. Further, it provides patient counselling services; design and construction services; and cannabis analytical product testing services. The company's brand portfolio includes Aurora, Aurora Drift, San Rafael '71, Daily Special, AltaVie, MedReleaf, CanniMed, Whistler, Woodstock, and ROAR Sports. Aurora Cannabis Inc. is headquartered in Edmonton, Canada. Address: Edmonton International Airport, Edmonton, AB, Canada, T9E 0V6

Technical Indicators

Unadjusted Closing Price

Adjusted Closing Price

Share Volume

Relative Performance (Total Returns)

Compare
Relative Returns (From:    To: 2020-11-29 )

Largest Industry Peers for Drug Manufacturers—Specialty & Generic

Symbol Name Price(Change) Market Cap Price / Earning Ratio EV/EBITDA
WEED:CA Canopy Growth Corporation

N/A

CAD13.96B N/A N/A
BHC:CA Bausch Health Companies Inc

N/A

CAD8.99B N/A 27.66
CRON:CA Cronos Group Inc

N/A

CAD3.86B 37.77 N/A
APHA:CA Aphria Inc

N/A

CAD2.93B 57.08 598.01
CWEB:CA Charlotte's Web Holdings, Inc

N/A

CAD0.93B 120.37 N/A
GUD:CA Knight Therapeutics Inc

N/A

CAD0.72B 27.74 7.77
HLS:CA HLS Therapeutics Inc

N/A

CAD0.59B N/A 45.29
HEXO:CA HEXO Corp

N/A

CAD0.55B N/A N/A
OGI:CA OrganiGram Holdings Inc

N/A

CAD0.39B -99,999.99 N/A
NEPT:CA Neptune Wellness Solutions Inc

N/A

CAD0.29B 32.20 N/A

ETFs Containing ACB:CA

Symbol Name Weight Mer Price(Change) Market Cap
HMMJ:CA Horizons Marijuana Life S.. 0.00 % 0.75 %

N/A

CAD0.33B
SEED:CA Evolve Marijuana Fund 0.00 % 0.75 %

N/A

CAD3.63M
HMMJ-U:CA Horizons Marijuana Life S.. 0.00 % 0.75 %

N/A

N/A

Market Performance

  Market Performance vs.
Industry/Classification (Drug Manufacturers—Specialty & Generic)
Market Performance vs. Exchange
  Value Sector Median Percentile Rank Grade Market Median Percentile Rank Grade
YTD  
Capital Gain -58.96% 23% F 3% F
Dividend Return N/A N/A N/A N/A N/A
Total Return -58.96% 23% F 3% F
Trailing 12 Months  
Capital Gain -65.51% 14% F 2% F
Dividend Return N/A N/A N/A N/A N/A
Total Return -65.51% 14% F 2% F
Trailing 5 Years  
Capital Gain 61.27% 75% C 76% C
Dividend Return N/A N/A N/A N/A N/A
Total Return 61.27% 75% C 74% C
Average Annual (5 Year Horizon)  
Capital Gain 136.66% N/A N/A 99% A+
Dividend Return N/A N/A N/A N/A N/A
Total Return 136.66% N/A N/A 99% A+
Risk Return Profile  
Volatility (Standard Deviation) 182.80% N/A N/A 2% F
Risk Adjusted Return 74.76% N/A N/A 83% B
Market Capitalization 2.52B 86% B 84% B
Letter Grade Percentage Letter Grade Percentage Letter Grade Percentage
A+ 97%-100% A 93%-96% A- 90%-92%
B+ 97%-89% B 83%-86% B- 80%-82%
C+ 77%-79% C 73%-76% C- 70%-72%
D+ 67%-69% D 63%-66% D- 60%-62%
F 0%-59%

Key Financial Ratios

  Ratio vs. Industry/Classification
(Drug Manufacturers—Specialty & Generic)
Ratio vs. Market
  Value Sector Median Percentile Rank Grade Market Median Percentile Rank Grade
Market Value  
Price / Earning Ratio 1,171.00 5% F 1% F
Price/Book Ratio 0.99 61% D- 68% D+
Price / Cash Flow Ratio -7.47 68% D+ 85% B
EV/EBITDA N/A N/A N/A N/A N/A
Management Effectiveness  
Return on Equity -103.28% 22% F 6% F
Return on Invested Capital -88.05% 21% F 3% F
Return on Assets -6.71% 50% F 18% F
Debt to Equity Ratio 13.71% 52% F 80% B-
Technical Ratios  
Short Ratio 0.96 75% C 51% F
Short Percent N/A N/A N/A N/A N/A
Beta 1.59 58% F 23% F
Letter Grade Percentage Letter Grade Percentage Letter Grade Percentage
A+ 97%-100% A 93%-96% A- 90%-92%
B+ 97%-89% B 83%-86% B- 80%-82%
C+ 77%-79% C 73%-76% C- 70%-72%
D+ 67%-69% D 63%-66% D- 60%-62%
F 0%-59%

Annual Financials (CAD)

Quarterly Financials (CAD)

Analyst Rating

Target Price Action Rating Action Analyst Rating Price Date

Fundamental Analysis Breakdown

This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.

What to like:
High market capitalization

This is one of the largest entities in its sector and is among the top quartile. Such companies tend to be more stable.

What to not like:
Overpriced compared to earnings

The stock is trading high compared to its peers on a price to earning basis and is above the sector median.

Negative cashflow

The company had negative total cash flow in the most recent four quarters.

Low Earnings Growth

This stock has shown below median earnings growth in the previous 5 years compared to its sector